Webinar: Regulatory interplay between medical devices and medicines - EU and U.S. hotspots

In vitro diagnostics are used to target molecular markers that identify patient subsets in which a treatment will be highly effective or, conversely, ineffective or even dangerous. Having proved their worth in clinical trials, such devices may be marketed as companion diagnostics. Novel methods of drug delivery may form part of a drug device combination, and may sometimes be supported by innovative software. 

Companies focusing on the research and development of pharmaceuticals are having to get to grips with the evolving regulatory framework for medical devices. This webinar will explore the inflection points between medicines and medical devices in research and clinical settings, comparing the EU and U.S. approaches to regulation.

The webinar will take place on Tuesday 6 June, 3PM (BST) / 4PM (CET) / 10AM (ET) / 7AM (PT). If you would like to attend, please reach out to your A&O contact.